131 related articles for article (PubMed ID: 31629104)
21. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
22. HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood.
Hocini H; Bonnabau H; Lacabaratz C; Lefebvre C; Tisserand P; Foucat E; Lelièvre JD; Lambotte O; Saez-Cirion A; Versmisse P; Thiébaut R; Lévy Y
J Virol; 2019 May; 93(10):. PubMed ID: 30814287
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients.
Monteleone K; Selvaggi C; Cacciotti G; Falasca F; Mezzaroma I; D'Ettorre G; Turriziani O; Vullo V; Antonelli G; Scagnolari C
BMC Infect Dis; 2015 Feb; 15():51. PubMed ID: 25808800
[TBL] [Abstract][Full Text] [Related]
24. Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapy.
Palmisano L; Giuliano M; Nicastri E; Pirillo MF; Andreotti M; Galluzzo CM; Bucciardini R; Fragola V; Andreoni M; Vella S
AIDS; 2005 Nov; 19(16):1843-7. PubMed ID: 16227792
[TBL] [Abstract][Full Text] [Related]
25. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
26. HIV infection deregulates innate immunity to malaria despite combination antiretroviral therapy.
Finney CA; Ayi K; Wasmuth JD; Sheth PM; Kaul R; Loutfy MR; Kain KC; Serghides L
AIDS; 2013 Jan; 27(3):325-35. PubMed ID: 23291537
[TBL] [Abstract][Full Text] [Related]
27. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
[TBL] [Abstract][Full Text] [Related]
28. Identification of molecular mechanisms for achieving HIV-1 control in the absence of antiretroviral therapy.
Hu X; Ni Y; Wang F; Ni Z; Jin T; Li Y; Ni M
Life Sci; 2021 Jan; 265():118857. PubMed ID: 33301809
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.
Højen JF; Rasmussen TA; Andersen KL; Winckelmann AA; Laursen RR; Gunst JD; Møller HJ; Fujita M; Østergaard L; Søgaard OS; Dinarello CA; Tolstrup M
Mol Med; 2015 Apr; 21(1):337-45. PubMed ID: 25879630
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of innate immune response genes in clinical phases of chronic hepatitis B infection.
Romani S; Hosseini SM; Mohebbi SR; Boonstra A; Sharifian A
J Viral Hepat; 2017 Sep; 24(9):776-788. PubMed ID: 28218976
[TBL] [Abstract][Full Text] [Related]
31. Concurrent CMV and EBV DNAemia is significantly correlated with a delay in the response to HAART in treatment-naive HIV type 1-positive patients.
Panagiotakis SH; Soufla G; Baritaki S; Sourvinos G; Passam A; Zagoreos I; Stavrianeas N; Spandidos DA
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):10-8. PubMed ID: 17263627
[TBL] [Abstract][Full Text] [Related]
32. Antiretroviral Therapy Fails to Restore Levels of HIV-1 Restriction miRNAs in PBMCs of HIV-1-infected MSM.
Liu MQ; Zhao M; Kong WH; Peng JS; Wang F; Qiu HY; Zhu ZR; Tang L; Sang M; Wu JG; Ho WZ; Zhou W
Medicine (Baltimore); 2015 Nov; 94(46):e2116. PubMed ID: 26579828
[TBL] [Abstract][Full Text] [Related]
33. [Interferon-regulating activity of the celagrip antiviral drug and its influence on formation of reactive oxygen species and expression of innate immunity genes in the follicular lymphoma patients].
Narovlyansky AN; Poloskov VV; Ivanova AM; Kravchenko SK; Babayeva FE; Sychevskaya KA; Mezentseva MV; Suetina IA; Russu LI; Izmest'eva AV; Ospelnikova TP; Sarymsakov AA; Ershov FI
Vopr Virusol; 2020 Nov; 65(5):284-293. PubMed ID: 33533212
[TBL] [Abstract][Full Text] [Related]
34. Analysis of inflammasomes and antiviral sensing components reveals decreased expression of NLRX1 in HIV-positive patients assuming efficient antiretroviral therapy.
Nasi M; De Biasi S; Bianchini E; Digaetano M; Pinti M; Gibellini L; Pecorini S; Carnevale G; Guaraldi G; Borghi V; Mussini C; Cossarizza A
AIDS; 2015 Sep; 29(15):1937-41. PubMed ID: 26237098
[TBL] [Abstract][Full Text] [Related]
35. Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master Group.
Clerici M; Seminari E; Suter F; Castelli F; Pan A; Biasin M; Colombo F; Trabattoni D; Maggiolo F; Carosi G; Maserati R
AIDS; 2000 Jan; 14(2):109-16. PubMed ID: 10708280
[TBL] [Abstract][Full Text] [Related]
36. Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study.
Avettand-Fenoel V; Blanche S; Le Chenadec J; Scott-Algara D; Dollfus C; Viard JP; Bouallag N; Benmebarek Y; Rivière Y; Warszawski J; Rouzioux C; Buseyne F
J Infect Dis; 2012 May; 205(10):1520-8. PubMed ID: 22427678
[TBL] [Abstract][Full Text] [Related]
37. Induction of OAS gene family in HIV monocyte infected patients with high and low viral load.
Fagone P; Nunnari G; Lazzara F; Longo A; Cambria D; Distefano G; Palumbo M; Nicoletti F; Malaguarnera L; Di Rosa M
Antiviral Res; 2016 Jul; 131():66-73. PubMed ID: 27107898
[TBL] [Abstract][Full Text] [Related]
38. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy.
Righetti E; Ballon G; Ometto L; Cattelan AM; Menin C; Zanchetta M; Chieco-Bianchi L; De Rossi A
AIDS; 2002 Jan; 16(1):63-73. PubMed ID: 11741164
[TBL] [Abstract][Full Text] [Related]
39. Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.
Otero M; Nunnari G; Leto D; Sullivan J; Wang FX; Frank I; Xu Y; Patel C; Dornadula G; Kulkosky J; Pomerantz RJ
AIDS Res Hum Retroviruses; 2003 Dec; 19(12):1097-103. PubMed ID: 14709246
[TBL] [Abstract][Full Text] [Related]
40. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
